We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$4.97B
AUM Growth
-$227M
Cap. Flow
-$120M
Cap. Flow %
-2.42%
Top 10 Hldgs %
24.91%
Holding
802
New
109
Increased
252
Reduced
267
Closed
54

Top Buys

Rank Stock Value
1
VTR icon
Ventas
VTR
+$29.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
ECL icon
Ecolab
ECL
+$25.4M
4
MRK icon
Merck
MRK
+$24.7M
5
EW icon
Edwards Lifesciences
EW
+$20.9M

Sector Composition

Rank Sector Weight
1 Healthcare 18.75%
2 Consumer Discretionary 15.42%
3 Technology 15.27%
4 Financials 12.99%
5 Industrials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AHT.PRD
201
Ashford Hospitality Trust Series D
AHT.PRD
$7.77M
$1.73M 0.03%
73,505
+1,010
+1% +$22.9K
TEVA icon
202
Teva Pharmaceuticals
TEVA
$43.8B
$1.72M 0.03%
32,093
+114
+0.4% +$6.69K
FDX icon
203
FedEx
FDX
$78.4B
$1.7M 0.03%
10,437
+200
+2% +$27.8K
WMT icon
204
Walmart Inc
WMT
$817B
$1.7M 0.03%
74,256
-501
-0.7% -$11K
UAL icon
205
United Airlines
UAL
$36.5B
$1.68M 0.03%
28,136
-31,548
-53% -$1.68M
MDT icon
206
Medtronic
MDT
$115B
$1.67M 0.03%
22,237
+593
+3% +$44.7K
MPLX icon
207
MPLX
MPLX
$60.3B
$1.65M 0.03%
55,625
+3,075
+6% +$83.4K
LOPE icon
208
Grand Canyon Education
LOPE
$3.91B
$1.65M 0.03%
38,482
-7,173
-16% -$276K
FULLL
209
DELISTED
Great Elm Capital Corp. 8.25% Notes due 2020
FULLL
$1.63M 0.03%
64,600
+6,205
+11% +$155K
CBRE icon
210
CBRE Group
CBRE
$42.6B
$1.6M 0.03%
55,637
-578,255
-91% -$15.9M
PFF icon
211
iShares Preferred and Income Securities ETF
PFF
$13.1B
$1.59M 0.03%
40,790
+25,318
+164% +$968K
TMO icon
212
Thermo Fisher Scientific
TMO
$233B
$1.54M 0.03%
10,913
-20
-0.2% -$2.68K
MHNB.CL
213
DELISTED
Maiden Holdings North America
MHNB.CL
$1.51M 0.03%
58,300
+13,200
+29% +$342K
LYB icon
214
LyondellBasell Industries
LYB
$20.4B
$1.51M 0.03%
17,677
-154,248
-90% -$12.4M
TROW icon
215
T. Rowe Price
TROW
$24B
$1.51M 0.03%
20,519
-134
-0.6% -$9.3K
TM icon
216
Toyota
TM
$227B
$1.5M 0.03%
14,087
-4,190
-23% -$463K
BWLD
217
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$1.49M 0.03%
10,075
-4,652
-32% -$711K
LKQ icon
218
LKQ Corp
LKQ
$6.42B
$1.49M 0.03%
46,526
+1,841
+4% +$51.3K
KIQ
219
DELISTED
Kelso Technologies Inc.
KIQ
$1.48M 0.03%
1,679,809
+52,000
+3% +$46.9K
XLF icon
220
State Street Financial Select Sector SPDR ETF
XLF
$56.4B
$1.47M 0.03%
74,479
-3,035
-4% -$57.8K
PX
221
DELISTED
Praxair Inc
PX
$1.45M 0.03%
12,651
+29
+0.2% +$3.03K
QQQ icon
222
Invesco QQQ Trust
QQQ
$493B
$1.44M 0.03%
13,201
-1,611
-11% -$167K
EXAM
223
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$1.43M 0.03%
48,450
-3,382
-7% -$91.9K
SMCI icon
224
Super Micro Computer
SMCI
$24.9B
$1.43M 0.03%
418,170
-201,170
-32% -$602K
LLY icon
225
Eli Lilly
LLY
$1.05T
$1.4M 0.03%
19,485
-1,397
-7% -$106K

Similar funds

Geneva Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Geneva Advisors held 802 positions worth $4.97B, down 4.4% from $5.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q1 2016 filing shows 109 new, 252 increased, 267 reduced and 54 closed positions. Its largest new stake was Ventas: 517,036 shares worth $32.6M. The largest sale was ServiceNow, an estimated $44M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Geneva Advisors's largest Q1 2016 buy was Ventas: 517,036 shares worth $32.6M.
  • Geneva Advisors added most to Bristol-Myers Squibb in Q1 2016, an estimated $28.3M increase.
  • Geneva Advisors's biggest Q1 2016 reduction was SBA Communications, cutting an estimated $43.3M.
  • Geneva Advisors fully exited ServiceNow in Q1 2016, selling an estimated $44M.
  • Geneva Advisors's ten largest holdings make up 25% of its $4.97B portfolio in Q1 2016.
  • Geneva Advisors opened 109 new positions and closed 54 in Q1 2016.
  • Geneva Advisors's portfolio value fell 4.4% quarter-over-quarter to $4.97B.

Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.